Prothena Corp Public (PRTA) Goodwill & Intangibles (2012 - 2013)
Prothena Corp Public's (PRTA) quarterly Goodwill & Intangibles came in at $44000.0 in Q1 2013, down 10.2% quarter-over-quarter from $49000.0 in Q4 2012.
Prothena Corp Public (PRTA) Goodwill & Intangibles (2012 - 2013) Analysis & Trends
Prothena Corp Public's Goodwill & Intangibles history runs 2 years deep, the most recent figure standing at $44000.0 for Q1 2013.
- On a quarterly basis, Goodwill & Intangibles changed N/A year-over-year to $44000.0 in Q1 2013; TTM through Mar 2013 was $44000.0, a N/A change from a year earlier, with the FY2012 full-year figure at $49000.0, changed N/A from the prior year.
- Goodwill & Intangibles fell to $44000.0 in Q1 2013 per PRTA's latest filing, from $49000.0 in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $49000.0 in Q4 2012 and bottomed at $44000.0 in Q1 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Prothena Corp Public | 458.13 Mn | 128.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 44,000.00 |
| Dec 31, 2012 | 49,000.00 |